AI assistant
Dabur India Ltd. Earnings Release 2025
59077_rns_2024-07-05_eb75e35f-7832-4a65-9407-aaa1e375d7e7.pdf
Earnings Release
Open in viewerOpens in your device viewer
Ref: SEC/SE/2024-25 Date: July 5, 2024
To, Corporate Relations Department BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street, Mumbai- 400001
National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor Plot No. C/1, G Block, Bandra Kurla Complex Bandra (E), Mumbai - 400051
BSE Scrip Code: 500096
NSE Scrip Symbol: DABUR
Sub: Quarterly Update- Q1 FY2024-25
Dear Sir/Madam,
Please find enclosed an update on the performance witnessed during the quarter ended June 30, 2024 (Q1 FY25).
This will be followed by detailed financial results and earnings presentation once the Board of Directors of the Company approves the consolidated and standalone financial results for the quarter ended June 30, 2024.
Thanking you,
Yours faithfully For Dabur India Limited
\ ASHOK JAIN
KUMAR 0a7e968110c5d0645b352ed6dfd1bc6aad8 147b3, pseudonym=459e115d99c240908ca599222 de2db9e, 2.5.4.20=08443b3bbbcf5f80cd46cc26add8 b8bdd652ffd20caa6b7340b03564e4b39dfa , email=[email protected], cn=ASHOK KUMAR JAIN Date: 2024.07.05 16:50:58 +05'30'
Digitally signed by ASHOK KUMAR JAIN DN: c=IN, postalCode=110092, st=DELHI, street=EAST DELHI, l=EAST DELHI, o=Personal, serialNumber=ecb3e1fdc2a028c70333c2d1
EVP (Finance) and Company Secretary
End: as above
^
Update for Quarter ended June 30, 2024 (Q1 FY25)
This update provides an overall summary of the performance and demand trends witnessed during the quarter ended June 30, 2024 (Q1 FY25). This will be followed by detailed financial results and earnings presentation once the Board of Directors of the Company approves the consolidated and standalone financial results for the quarter ended June 30, 2024.
The quarter saw sequential improvement in demand trends with rural growth picking up. With forecast of a normal monsoon and continued focus by the government on macro-economic growth, we expect the improvement to accelerate in the coming months.
Dabur's consolidated revenue is expected to register mid to high single digit growth during Q1 FY25. India business is expected to record mid-single digit volume growth.
In India business, HPC & Healthcare segment is expected to grow in high-single digits. Travel and out of home consumption got impacted due to scorching summers, which had an impact on our beverage segment although the food (culinary) category showed good momentum. Badshah Masala continued to perform well and is expected to post strong volume led growth in high teens.
The International Business is expected to post strong growth in constant currency terms. However severe currency depreciation in Turkey and Egypt continued to have an impact on translated growth.
Commodity prices were stable during the quarter. Gross margins are likely to witness some expansion on account of roll over price increases and cost-saving initiatives. The business continued to invest strongly behind the brands with A&P spends growing ahead of revenue. Consequently, the operating profit is expected to grow marginally ahead of revenue.
We continue to focus on our strategy to increase our distribution reach, invest aggressively on our key brands and drive increase in our market shares across the portfolio.
About Dabur India Ltd
Dabur India Limited is one of India's leading FMCG Companies. Building on a legacy of quality and experience for 140 years, Dabur is today India's most trusted name and one of the world's largest Ayurvedic and Natural Health Care Company. Dabur India's FMCG portfolio today includes nine distinct Power Brands: Dabur Chyawanprash, Dabur Honey, Dabur Honitus, Dabur PudinHara and Dabur Lal Tail in the Healthcare space; Dabur Amla, Dabur Red Paste and Vatika in the Personal Care category; and Real in the Foods space. During FY 2023-24, Dabur recorded consolidated revenue from operations of INR 12,404 crore and consolidated profit after tax of INR 1,843 crore.
For further information please contact:
Isha Lamba Email: [email protected]
Ayush Goyal Email: [email protected]
Disclaimer:
The statements and financials disclosed above may differ from the reported financials to reflect the real business financial performance. Some of the statements in this communication may be forward looking statements within the meaning of applicable laws and regulations. Actual results might differ substantially from those expressed or implied.
